Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women's Hospital, Boston, Massachusetts 02115, United States.
Mol Pharm. 2010 Dec 6;7(6):1913-20. doi: 10.1021/mp100253e. Epub 2010 Oct 27.
First-generation nanoparticles (NPs) have been clinically translated as pharmaceutical drug delivery carriers for their ability to improve on drug tolerability, circulation half-life, and efficacy. Toward the development of the next-generation NPs, researchers have designed novel multifunctional platforms for sustained release, molecular targeting, and environmental responsiveness. This review focuses on environmentally responsive mechanisms used in NP designs, and highlights the use of pH-responsive NPs in drug delivery. Different organs, tissues, and subcellular compartments, as well as their pathophysiological states, can be characterized by their pH levels and gradients. When exposed to these pH stimuli, pH-responsive NPs respond with physicochemical changes to their material structure and surface characteristics. These include swelling, dissociating or surface charge switching, in a manner that favors drug release at the target site over surrounding tissues. The novel developments described here may revise the classical outlook that NPs are passive delivery vehicles, in favor of responsive, sensing vehicles that use environmental cues to achieve maximal drug potency.
第一代纳米颗粒 (NPs) 已被临床转化为药物递送载体,因其能够提高药物耐受性、循环半衰期和疗效。为了开发下一代 NPs,研究人员设计了新型多功能平台,用于持续释放、分子靶向和环境响应。本综述重点介绍了 NP 设计中使用的环境响应机制,并强调了 pH 响应 NPs 在药物递送中的应用。不同的器官、组织和亚细胞区室以及它们的病理生理状态可以通过 pH 值和 pH 梯度来表征。当暴露于这些 pH 刺激时,pH 响应 NPs 会对其材料结构和表面特性发生物理化学变化。这些变化包括溶胀、解离或表面电荷转换,有利于药物在靶部位释放,而不是在周围组织中释放。这里描述的新进展可能会修正 NPs 是被动递送载体的经典观点,转而支持使用环境线索来实现最大药物效力的响应性、感应性载体。